Developing new influenza vaccines for better protection against flu strains
Collaborative Influenza Vaccine Innovation Centers (CIVICs)
This study is looking for ways to make better flu vaccines that can help keep you protected from different types of the flu for a longer time, and you might have the chance to join a trial to see how well these new vaccines work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11257990 on NIH RePORTER |
What this research studies
This research focuses on creating and testing innovative influenza vaccine candidates that can provide long-lasting immunity against various strains of the flu virus. It involves analyzing immune responses to inform the design of these vaccines and conducting both laboratory and clinical tests to evaluate their effectiveness. Patients may participate in clinical trials that assess how well these new vaccines work in generating immunity and protecting against influenza. The research aims to improve vaccine delivery methods and overall efficacy.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at higher risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective influenza vaccines that provide broader and longer-lasting protection against multiple flu strains.
How similar studies have performed: Previous research has shown promise in developing innovative vaccine approaches, indicating potential for success in this area.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Moody, Tony — Duke University
- Study coordinator: Moody, Tony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.